Premium
Allele frequencies of human platelet antigens in Banjar, Bugis, Champa, Jawa and Kelantan Malays in Peninsular Malaysia
Author(s) -
Wan Syafawati W. U.,
Norhalifah H. K.,
Zefarina Z.,
Zafarina Z.,
Panneerchelvam S.,
Norazmi M. N.,
Chambers G. K.,
Edinur H. A.
Publication year - 2015
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12220
Subject(s) - malay , genotyping , ethnic group , allele , demography , biology , allele frequency , polymerase chain reaction , traditional medicine , veterinary medicine , genetics , gene , medicine , genotype , sociology , anthropology , philosophy , linguistics
SUMMARY Objectives The major aims of this study are to characterise and compile allelic data of human platelet antigen ( HPA )‐1 to ‐6 and ‐15 systems in five Malay sub‐ethnic groups in Peninsular Malaysia. Background HPAs are polymorphic glycoproteins expressed on the surface of platelet membranes and are genetically differentiated across ethnogeographically unrelated populations. Methods Blood samples were obtained with informed consent from 192 volunteers: Banjar ( n = 30), Bugis ( n = 37), Champa ( n = 51), Jawa ( n = 39) and Kelantan ( n = 35). Genotyping was done using polymerase chain reaction‐sequence specific primer method. Results In general, frequencies of HPAs in the Malay sub‐ethnic groups are more similar to those in Asian populations compared with other more distinct populations such as Indians, Australian Aborigines and Europeans. Conclusions This study provides the first HPA datasets for the selected Malay sub‐ethnic groups. Subsequent analyses including previously reported HPA data of Malays, Chinese and Indians revealed details of the genetic relationships and ancestry of various sub‐populations in Peninsular Malaysia. Furthermore, the comprehensive HPA allele frequency information from Peninsular Malaysia provided in this report has potential applications for future study of diseases, estimating risks associated with HPA alloimmunization and for developing an efficient HPA ‐typed donor recruitment strategy.